THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 61 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $30,000 | -3.2% | 65,352 | 0.0% | 0.00% | – |
| Q4 2015 | $31,000 | -87.2% | 65,352 | +10.0% | 0.00% | -100.0% |
| Q3 2015 | $242,000 | +4.8% | 59,427 | +3.7% | 0.00% | 0.0% |
| Q2 2015 | $231,000 | -2.5% | 57,286 | -1.9% | 0.00% | 0.0% |
| Q1 2015 | $237,000 | +68.1% | 58,421 | +32.1% | 0.00% | – |
| Q4 2014 | $141,000 | -8.4% | 44,221 | +3.6% | 0.00% | – |
| Q3 2014 | $154,000 | -8.9% | 42,671 | 0.0% | 0.00% | – |
| Q2 2014 | $169,000 | -10.6% | 42,671 | +7.7% | 0.00% | -100.0% |
| Q1 2014 | $189,000 | -3.6% | 39,633 | -5.5% | 0.00% | 0.0% |
| Q4 2013 | $196,000 | -3.0% | 41,923 | -3.7% | 0.00% | 0.0% |
| Q3 2013 | $202,000 | -9.4% | 43,523 | +2.7% | 0.00% | 0.0% |
| Q2 2013 | $223,000 | – | 42,370 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 625,558 | $2,540,000 | 1.95% |
| CG Asset Management LLC | 128,000 | $520,000 | 0.20% |
| Rotella Capital Management, Inc. | 45,364 | $184,000 | 0.15% |
| TFS CAPITAL LLC | 348,617 | $1,415,000 | 0.14% |
| Rhenman & Partners Asset Management AB | 201,537 | $818,000 | 0.14% |
| FORTALEZA ASSET MANAGEMENT INC/ | 59,180 | $240,000 | 0.14% |
| Baker Brothers Advisors | 2,925,519 | $11,878,000 | 0.10% |
| FEDERATED HERMES, INC. | 3,918,305 | $15,908,000 | 0.05% |
| FRANKLIN STREET ADVISORS INC /NC | 50,000 | $203,000 | 0.04% |
| Princeton Alpha Management LP | 26,560 | $108,000 | 0.02% |